Characterization and functional effects of cemtirestat a potent aldo keto reductase inhibitor in diabetes and inflammation

2015-06-12
Prnova, Marta
Magdalena, Majekova
Ballekova, Jana
Ceyhan, Muşerref
Enayat, Shabnam
Banerjee, Sreeparna
Stefek, Milan
Aldo-keto reductases (AKR) are NAD(P)H dependent oxidoreductases that have been best characterized as glucose reducing agents, and have been implicated in diabetic pathophysiology. The first enzyme of the polyol pathway, aldose reductase (AKR1B1) is involved in the molecular mechanisms of glucose toxicity leading to diabetic complications, including microvascular, neurological, and macrovascular disorders, which are responsible for significant increase in morbidity and mortality of diabetic patients. These enzymes are also known to mediate an inflammatory response to lipid peroxidation metabolic products. Since chronic inflammation is associated with a number of pathological states, AKR1B1 has been implicated in various inflammatory diseases such as atherosclerosis, asthma, uveitis, sepsis, arthritis, periodontitis and several types of cancer related to chronic inflammation. Recently novel aldose reductase inhibitors based on carboxymethylated mercapto-triazino-indole scaffold have been designed [1]. Among the novel compounds, cemtirestat (Fig. 1) was the most promising inhibitor, with an IC50 in submicromolar range and high selectivity.
11th International Symposium on Pharmaceutical Sciences (ISOPS-11), (9 - 12 Haziran 2015)

Suggestions

PREPARATION AND CHARACTERIZATION OF POLYMER COATED SMALL UNILAMELLAR VESICLES
OZDEN, MY; Hasırcı, Vasıf Nejat (1991-09-02)
Glucose oxidase was entrapped in small unilamellar vesicles composed of phosphatidylcholine, dicetyl phosphate and cholesterol. Prediction of the enzyme content of liposomes by calculations based on input concentrations of lipid and protein, dimensions of the lipids and the liposomes yielded one protein per vesicle. The entrapment efficiency was experimentally determined to be about 13%. On the other hand the entrapment efficiency for the small chromate ions was found to be significantly lower (0.1%). T...
Evaluation of functional changes in akr1b1 and akr1b10 overexpressing colorectal cancer cell lines
Güderer, İsmail; Banerjee, Sreeparna; Department of Biology (2021-2-15)
Aldo-keto reductases (AKRs) are nicotinamide adenine dinucleotide phosphate (NADPH)-dependent enzymes with diverse cellular metabolism functions. AKR1B1 and AKR1B10 are two of the most studied enzymes in the AKR family. AKR1B1 reduces excess glucose into sorbitol using reducing electrons from NADPH, and the hyperactivation of the AKR1B1 pathways is associated with oxidative stress and cell death. AKR1B10 is a poor reductant of glucose but is a vital enzyme that can metabolize retinol and many other drugs an...
Investigation of bioprocess parameters for glucose isomerase production by Bacillus thermoantarcticus
Haykır, Işık; Çalık, Pınar; Department of Chemical Engineering (2007)
In this study, the effects of bioprocess parameters on glucose isomerase roduction by Bacillus thermoantarcticus (DSMZ 9572) were investigated. For his purpose, firstly, in laboratory scale shake-bioreactors, a defined medium was designed in terms of its carbon and nitrogen sources, to achieve the highest glucose isomerase activity. Optimum concentrations of medium components were determined by a statistical approach, namely Response Surface Methodology (RSM). RSM defined the relationship between the respon...
Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway
Canli, Secil Demirkol; Seza, Esin Gulce; Sheraj, Ilir; Gomceli, Ismail; Turhan, Nesrin; Carberry, Steven; Prehn, Jochen H. M.; GÜRE, ALİ OSMAY; Banerjee, Sreeparna (Oxford University Press (OUP), 2020-09-01)
AKR1B1 and AKR1B10, members of the aldo-keto reductase family of enzymes that participate in the polyol pathway of aldehyde metabolism, are aberrantly expressed in colon cancer. We previously showed that high expression of AKR1B1 (AKR1B1(HIGH)) was associated with enhanced motility, inflammation and poor clinical outcome in colon cancer patients. Using publicly available datasets and ex vivo gene expression analysis (n = 51, Ankara cohort), we have validated our previous in silico finding that AKR1B1(HIGH) ...
Effects of the quercetin derivative CHNQ, a potent aldo- keto reductase inhibitor, on akr1b1 silenced HCT-116 colorectal cancer cells
Taşkoparan, Betül; Banerjee, Sreeparna; Department of Biology (2016)
Aldo-keto reductases (AKRs) are NAD(P)H dependent oxidoreductases that are known to be involved in the biosynthesis, metabolism and detoxification of a number of substrates including glucose. These enzymes are therefore implicated in the development of diabetic complications. Additionally, this family of enzymes, particularly AKR1B1, has been shown to be involved in pathology of inflammation- associated diseases such as atherosclerosis, asthma, uveitis, sepsis, arthritis, periodontitis and cancer, including...
Citation Formats
M. Prnova et al., “Characterization and functional effects of cemtirestat a potent aldo keto reductase inhibitor in diabetes and inflammation,” presented at the 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), (9 - 12 Haziran 2015), Ankara, Türkiye, 2015, Accessed: 00, 2021. [Online]. Available: https://hdl.handle.net/11511/75060.